JNJ
Johnson & JohnsonNYSEResearch view
Healthcare · Pharmaceutical Preparations · Mega-cap · SEC EDGAR FY 2025-12-28
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-28SectorHealthcare
Market Cap$643.9B
Enterprise Value$674.2B
Income$26.8B
Sales$94.2B
Book/sh$33.84
Cash/sh$8.18
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio0.77
Current Ratio1.03
Debt/Eq0.61
EPS (ttm)$11.03
EPS this Y90.5%
EPS past 3/5Y17.9%
Sales past 3/5Y5.6%
EPS Y/Y TTM90.5%
Sales Y/Y TTM6.0%
Shs Outstand2.41B
ROA13.5%
ROE32.9%
ROIC15.9%
Gross Margin67.9%
Oper. Margin22.9%
Profit Margin28.5%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$78.7B
2022
$80.0B
2023
$85.2B
2023
$88.8B
2024
$94.2B
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $78.7B | $80.0B | $85.2B | $88.8B | $94.2B |
| Gross Profit | $55.3B | $55.4B | $58.6B | $61.4B | $63.9B |
| Operating Income | — | — | — | — | — |
| Net Income | $20.9B | $17.9B | $35.2B | $14.1B | $26.8B |
| Diluted EPS | $7.81 | $6.73 | $13.72 | $5.79 | $11.03 |
| Operating Cash Flow | $23.4B | $21.2B | $22.8B | $24.3B | $24.5B |
| Free Cash Flow | $19.8B | $17.2B | $18.2B | $19.8B | $19.7B |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY25 cash-flow waterfall
Capital-light: capex is $4.8B against $24.5B operating cash
COMMUNITY · $JNJ0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Pharmaceutical Preparations
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.